Here, we show that the pro-survival BCL2 family pool is biased towards MCL1 in melanoma compared to CRC, NSCLC and pancreatic tumour lineages, due to low BCL-XL expression. The gene discussed is BCL2L1; the disease is pancreatic neoplasm.